COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents

被引：6
|
作者：
Vorster, Luna [1 ]
Kirk, Susan E. [2 ]
Muscal, Eyal [3 ,4 ]
Despotovic, Jenny M. [2 ]
Cohen, Clay T. [2 ]
Sartain, Sarah E. [2 ]
机构：
[1] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Hematol Oncol, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Rheumatol, Houston, TX USA
[4] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Neurol Dev Neurosci, Houston, TX USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷 / 06期
关键词：
acquired TTP; COVID-19; TTP; vaccination; ADAMTS13;
D O I：
10.1002/pbc.29681
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The mRNA COVID-19 vaccine and COVID-19 infection caused by the SARS-CoV-2 virus may be immunologic triggers for the development of thrombotic thrombocytopenic purpura (TTP). There is not yet literature that discusses TTP induced by COVID-19 vaccination or infection in pediatric or adolescent patients. We describe three adolescents presenting with TTP (both de novo and relapsed disease) following administration of the Pfizer COVID-19 vaccine or after COVID-19 infection. Our observations demonstrate that the Pfizer-BioNTech mRNA vaccine and COVID-19 infection can act as triggers for the development/relapse of both congenital and acquired TTP.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Comment on: COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69 (12)
  • [2] BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura
    Ghosh, A. K.
    Bhushan, S.
    Lopez, L. D. R.
    Sampat, D.
    Salah, Z.
    Hatoum, C. A.
    [J]. CASE REPORTS IN MEDICINE, 2022, 2022
  • [3] Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
    Johannes Ruhe
    Ulf Schnetzke
    Karim Kentouche
    Florian Prims
    Michael Baier
    Konstantin Herfurth
    Mandy Schlosser
    Martin Busch
    Andreas Hochhaus
    Gunter Wolf
    [J]. Annals of Hematology, 2022, 101 : 717 - 719
  • [4] Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
    Ruhe, Johannes
    Schnetzke, Ulf
    Kentouche, Karim
    Prims, Florian
    Baier, Michael
    Herfurth, Konstantin
    Schlosser, Mandy
    Busch, Martin
    Hochhaus, Andreas
    Wolf, Gunter
    [J]. ANNALS OF HEMATOLOGY, 2022, 101 (03) : 717 - 719
  • [5] BNT162b2 Covid-19 Vaccine in Adolescents
    Lin, Chen-Hsing
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14): : 1342 - 1343
  • [6] Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
    Mansanguan, Suyanee
    Charunwatthana, Prakaykaew
    Piyaphanee, Watcharapong
    Dechkhajorn, Wilanee
    Poolcharoen, Akkapon
    Mansanguan, Chayasin
    [J]. TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (08)
  • [7] Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents
    Choe, Young June
    Yi, Seonju
    Hwang, Insob
    Kim, Jia
    Park, Young-Joon
    Cho, Eunhee
    Jo, Myoungyoun
    Lee, Hyunju
    Choi, Eun Hwa
    [J]. VACCINE, 2022, 40 (05) : 691 - 694
  • [8] BNT162b2 Covid-19 Vaccine in Adolescents REPLY
    Frenck, Robert W., Jr.
    Dormitzer, Philip R.
    Gurtman, Alejandra
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14): : 1343 - 1343
  • [9] BNT162b2 COVID-19 vaccine
    不详
    [J]. AUSTRALIAN PRESCRIBER, 2021, 44 (02) : 57 - 58
  • [10] Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine: Case Report and Literature Review
    Hammami, Emna
    Lamarque, Mathilde
    Aujoulat, Olivier
    Debliquis, Agathe
    Drenou, Bernard
    Harzallah, Ines
    [J]. LABORATORY MEDICINE, 2022, 53 (06) : E145 - E148
12345